DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION
Loading...
  • Stocks
  • /
  • Capital Goods
Updated 1d ago
OCR logo

Octopus Biosafety SABST:OCR Stock Report

Market Cap €21.1m
Updated 1d ago
Share Price
n/a
1Yn/a
7D275.0%
1D0%
Portfolio Value
​
View

Octopus Biosafety SA

BST:OCR Stock Report

Market Cap: €21.1m

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Octopus Biosafety (OCR) Stock Overview

Engages in designing, manufacturing, and marketing of mobile, autonomous, intelligent, and modular robots for poultry industry in France and internationally. More details

OCR fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Risk Analysis

Latest financial reports are more than a year old

Shares are highly illiquid

Does not have a meaningful market cap (€21M)


OCR Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW443,467 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
B
BlackGoat
R
RockeTeller
I
Investingwilly
D
davidlsander
443,467 investors already sharing narratives
€
Current Price
€0.153.7k% overvalued intrinsic discount
%/yr
Decrease
Increase
PastFuture-2m662k2016201920222025202620282031Revenue €385.1kEarnings €36.6k
Advanced
View all narratives

Octopus Biosafety SA Competitors

Aerowash

Symbol: DB:1HV
Market cap: €23.7m

DATRON

Symbol: XTRA:DAR
Market cap: €36.1m

Alexanderwerk

Symbol: DB:ALXA
Market cap: €44.6m

Xoma

Symbol: DB:QM8
Market cap: €43.1m

Price History & Performance

Summary of share price highs, lows and changes for Octopus Biosafety
Historical stock prices
Current Share Price€0.15
52 Week High€0.15
52 Week Low€0.04
Beta0
1 Month Change15.38%
3 Month Changen/a
1 Year Changen/a
3 Year Change-25.00%
5 Year Change-81.75%
Change since IPO-97.46%

Recent News & Updates

Recent updates

Shareholder Returns

OCRDE MachineryDE Market
7D275.0%-2.7%-1.5%
1Yn/a2.2%4.0%

Return vs Industry: Insufficient data to determine how OCR performed against the German Machinery industry.

Return vs Market: Insufficient data to determine how OCR performed against the German Market.

Price Volatility

Is OCR's price volatile compared to industry and market?
OCR volatility
OCR Average Weekly Movementn/a
Machinery Industry Average Movement4.3%
Market Average Movement5.0%
10% most volatile stocks in DE Market12.2%
10% least volatile stocks in DE Market2.5%

Stable Share Price: OCR's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine OCR's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
19876Bertrand Vergnewww.octopusbiosafety.com

Octopus Biosafety SA engages in designing, manufacturing, and marketing of mobile, autonomous, intelligent, and modular robots for poultry industry in France and internationally. It offers XO, a continuous litter treatment, and environmental and animal monitoring solution for poultry farming; T-MOOV, a robot that keeps the birds moving and reduces the count of floor eggs; and Easy-LIT, an electric scarifier that helps in simplifying the maintenance of litter without noise and dust, as well as without lifting the equipment and risking injury to the poultry. Octopus Biosafety SA was incorporated in 1987 and is headquartered in Auray, France.

Octopus Biosafety SA Fundamentals Summary

How do Octopus Biosafety's earnings and revenue compare to its market cap?
OCR fundamental statistics
Market cap€21.10m
Earnings (TTM)-€659.11k
Revenue (TTM)€385.11k
0.0x
P/S Ratio
0.0x
P/E Ratio

Is OCR overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
OCR income statement (TTM)
Revenue€385.11k
Cost of Revenue€721.41k
Gross Profit-€336.29k
Other Expenses€322.81k
Earnings-€659.11k

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did OCR perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/14 02:52
End of Day Share Price 2026/09/14 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Octopus Biosafety SA is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide